Mainland China
Breakthrough in the electrification of commercial vehicles: CATL Unveils Revolutionary TECTRANS Battery System
HANOVER, Germany, Sept. 17, 2024 /PRNewswire/ -- At IAA Transportation 2024,
Contemporary Amperex Technology Co., Limited (CATL), the global leader in new
energy technology innovations launched its groundbreaking TECTRANS battery
system, revolutionizing the commercial transportation sector.
2024-09-17 23:05
2264
Datasea's New 5G AI Multimodal Agreements Have Already Generated $9.0 Million of 5G-AI Services
Agreements Boost Fiscal 2025 Revenue and Expand Datasea's 5G Application Market Positioning inChina BEIJING, Sept. 17, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada-based company focused on innovative high-tech acoustics and 5G-Artificial Intelligence ("A...
2024-09-17 21:45
1626
Ascletis Enters the Obesity Drug Space with Announcement of Two Ongoing U.S. Phase I Clinical Trials Utilizing Its Small Molecule GLP-1R Agonist ASC30 for Both Once-Monthly Subcutaneous Injection and Once-Daily Oral Tablet for the Treatment of Obesity
- ASC30 is the first and only small molecule GLP-1 receptor (GLP-1R) agonist that can be dosed once-monthly subcutaneously and once-daily orally to treat obesity - ASC30 is two- to threefold more potent, in vitro, than orforglipron and stimulated significantly greater insulin secretion when comp...
2024-09-17 18:25
2160
Subgroup Analysis from Pivotal WU-KONG1B Study Exhibits Robust Efficacy of Sunvozertinib in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations Across Different Baseline Characteristics
Results of subgroup analysis from the pivotal WU-KONG1B study in relapsed or refractory NSCLC with EGFR exon20ins presented at ESMO 2024 * Sunvozertinib demonstrated promising anti-tumor efficacy, regardless of EGFR exon20ins region classification, race, region, baseline brain metastasis, prio...
2024-09-17 15:47
1857
The Spectacular Premiere of Jiangsu's Original Ethnic Dance Drama A Dream of Red Mansions in Singapore
SINGAPORE, Sept. 17, 2024 /PRNewswire/ -- With translucent white light illuminating the stage and silk curtains drawn low, the twelve heroines of A Dream of Red Mansions gracefully swayed their way forward, leading the audience into a shared dream. As the performance concluded, actors took multip...
2024-09-17 14:29
1517
Cooperation zone's successes celebrated in anniversary publication
Eight-page spread highlights series of achievements made in Hengqin BEIJING, Sept. 16, 2024 /PRNewswire/ -- In collaboration with the Guangdong-Macao In-Depth Cooperation Zone in Hengqin,China Daily published an eight-page spread on Tuesday to celebrate the third anniversary of the zone's foundi...
2024-09-17 10:00
1454
Steelhead LNG Initiates Patent Infringement Litigation Against Cedar LNG and Samsung Heavy Industries in Korea
VANCOUVER, BC, Sept. 16, 2024 /PRNewswire/ -- Steelhead LNG, a Vancouver-based developer in the liquefied natural gas (LNG) industry, today announced the commencement of patent infringement proceedings against [Cedar LNG] and Samsung Heavy Industries Co., Ltd. ("Samsung Heavy") in the Republic of...
2024-09-17 06:00
2050
State Grid Heze Power Supply Company: high-quality power service boost autumn peach fragrance
HEZE, China, Sept. 16, 2024 /PRNewswire/ -- On September 5, in the Yellow River beach district of Shandong Province Heze Kuigudui Village, Juancheng County rich farmers fruit planting base, the staff is busy picking in the peach orchard, not for a while, the car has been full of baskets, then pul...
2024-09-16 22:01
2020
Kstar Wins Multiple Accolades in Data Center Infrastructure Industry
SHENZHEN, China, Sept. 16, 2024 /PRNewswire/ -- Kstar, a prominent player in
data center infrastructure, has been recognized byChina's top research
institutions CCID Consulting and ICT research, for its excellence in various
segments, includingUPS systems
2024-09-16 21:00
1796
Huawei Teases New Pro-level MatePad, with Groundbreaking Display and Updated GoPaint App
BARCELONA, Spain, Sept. 16, 2024 /PRNewswire/ -- Huawei is said to be launching a new MatePad Pro Series tablet during its launch inBarcelona this September. An intersection of power-packed innovation and artistic inspiration, the tablet is said to be introducing a groundbreaking upgrade of its d...
2024-09-16 20:26
2525
Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment
BEIJING, Sept. 16, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that Guangzhou Concord Cancer Center ("Guangzhou H...
2024-09-16 20:00
1979
Vazyme Leads Life Science Innovation, Boosting Research Breakthroughs in mIDH1 Cancer Treatment
NANJING, China, Sept. 16, 2024 /PRNewswire/ -- Vazyme (688105.SH), a leading life science technology company, significantly contributed to groundbreaking research published in Science Magazine through its innovative products. The study, which focuses on how mutant IDH1 inhibition activates tumor ...
2024-09-16 19:00
1790
Antennova Releases Latest Data of CD73 Inhibitor ATN-037, including a DCR of 89.5%, in a Mini Oral at ESMO Congress 2024
* In patients with non-small cell lung cancer (NSCLC) or melanoma who had acquired resistance to checkpoint inhibitors (CPIs), ATN-037 in combination with KEYTRUDA®(pembrolizumab) demonstrated an overall response rate (ORR) of 21.1% and a disease control rate (DCR) of 89.5%. * Data from the...
2024-09-16 18:00
2040
China Automotive Systems Announces Annual Meeting on September 24, 2024
CAAS announces the conference call and webcast information for the Annual Meeting of Stockholders to be held onTuesday, September 24, 2024 at 9:00 AM local time, or 9:00 PM EDT onMonday, September 23, 2024 WUHAN, China, Sept. 16, 2024 /PRNewswire/ -- China Automotive Systems, Inc. (Nasdaq: CAAS)...
2024-09-16 18:00
4405
From Maritime Silk Road Hub to "Trade Window": Guangdong's Continuous Push for Opening Up
GUANGDONG, China, Sept. 16, 2024 /PRNewswire/ -- Since the Tang Dynasty
(618-907), Guangzhou inGuangdong Province has been a prominent port where
Sino-foreign trade flourished, attracting numerous foreign merchants who
traveled here along the Maritime Silk Road.
2024-09-16 17:15
2229
Alphamab Oncology Presented the Latest Clinical Data from Two Studies on Anti-HER2 Bispecific ADC JSKN003 at the ESMO Congress 2024
SUZHOU, China, Sept. 16, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from two studies on anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 were presented at the 2024 European Society for Medical Oncology Congress (ESMO Congress 202...
2024-09-16 13:03
1958
Risen Energy Champions Environmental Stewardship for a Greener Future
NINGBO, China, Sept. 15, 2024 /PRNewswire/ -- On September 20, World Cleanup Day 2024 kicks off during the Clean Up the World Weekend (CUW Weekend), themed "make room for life." Since joining the UN Global Compact (UNGC) in 2021, Risen Energy, a leader in global photovoltaic (PV) innovation, has ...
2024-09-16 10:00
1726
Temple Mall Presents "Blue-and-White Porcelain Impressions" Art Experience
Collaborating with Local Artist Angel Hui to Explore the Beauty of a Millennia-old Cultural Treasure * Temple Mall presents a themed event and exhibition celebrating blue-and-white porcelain, inviting the public to explore and appreciate the rich heritage of this millennia-old cultural treasur...
2024-09-16 09:00
2697
ESMO 2024 - ImmVira Unveils Clinical Results of Intravesical MVR-T3011 for High-Risk BCG-Failure NMIBC Patients
SHENZHEN, China, Sept. 15, 2024 /PRNewswire/ -- ImmVira announced the latest clinical results for its lead oncolytic virus product, MVR-T3011, via intravesical administration in patients with high-risk BCG-failure non-muscle invasive bladder cancer (NMIBC). The results were published through post...
2024-09-15 17:53
3132
Akeso Published Ivonescimab plus Ligufalimab as First-Line Treatment for PD-L1-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at ESMO 2024
Head-to-Head Phase 3 Trial Compared to Pembrolizumab Initiated HONG KONG, Sept. 15, 2024 /PRNewswire/ -- At the 2024 European Society for Medical Oncology (ESMO) Conference, Akeso released the Phase 2 clinical results of its internally developed PD-1/VEGF bispecific antibody, ivonescimab, with or...
2024-09-15 15:10
2939
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
7433
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
6834
